Foundation for innovation
in Cardiometabolism and Nutrition

IHU-ICAN

Communication

TRaining

clinical TEams

Cardiometabolism

INnovative care Pathways

Reference Centers

Research Teams

research

research focus Area

Our Support

clinical Investigation

scientific Plateforms

Parterships

Why Support ICAN?

How to support ICAN?

projects to Support

News

  • The IHU ICAN is participating in a groundbreaking initiative to combat metabolic cardio-renal diseases

    The IHU ICAN is participating in a groundbreaking initiative to combat metabolic cardio-renal diseases

    ,
    Read more
  • Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

    Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

    Read more
  • The Urgency of Preventing Cardiometabolic Diseases

    The Urgency of Preventing Cardiometabolic Diseases

    ,
    Read more
  • What were the key takeaways from the symposium on "Prevention of Cardiometabolic Diseases" held at the Ministry of Health?

    What were the key takeaways from the symposium on "Prevention of Cardiometabolic Diseases" held at the Ministry of Health?

    ,
    Read more
  • ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

    ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

    ,
    Read more
  • Understanding the link between obesity and nutrition to take better action

    Understanding the link between obesity and nutrition to take better action

    Read more
  • The women driving cardiometabolic research forward at the IHU ICAN

    The women driving cardiometabolic research forward at the IHU ICAN

    Read more
  • Sudden adult death: LE TRIOMPHE DU COEUR continues its commitment to the IHU ICAN

    Sudden adult death: LE TRIOMPHE DU COEUR continues its commitment to the IHU ICAN

    Read more
  • Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

    Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

    Read more
  • Heading for 2026: thank you for your commitment to our cause!

    Heading for 2026: thank you for your commitment to our cause!

    ,
    Read more

Stay in touch

Get all the latest news from the ICAN Foundation

This field is for validation purposes and should be left unchanged.

OUr founders

ISO 9001 Certified

OUr Institutionnal Supporters

Our network